©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.113475
Table 7 Cut-off validation against established thresholds
| Marker | Established cut-off | Our cut-off | Clinical utility |
| FIB-4 | > 1.45 (rule-out) | > 1.42 | Equivalent rule-out |
| APRI | > 0.7 (significant) | > 0.68 | Validated threshold |
| PLR | Novel marker | > 142.5 | Exploratory |
| NPAR | Novel marker | > 14.13 | Exploratory |
- Citation: Joseph A, Mathew S, Nair HR. Blood markers vs transient elastography for liver stiffness and steatosis in metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2026; 18(1): 113475
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/113475.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.113475